
Overview
Background
I lead the Technology-Driven Drug Discovery (Tech3D) Group at the Institute for Molecular Bioscience, UQ. We believe that the key to solving some of our world's biggest challenges, whether that be in medicine or agriculture, relies on the ability to precision engineer molecules at will. My group harnesses three technological pillars to engineer peptides and proteins, which are computational biology, molecular libraries, and nanotechnology. We aspire to design better drugs, creating next generation biotechnological agents that have real impact. These could be new cancer drugs that harness the body's immune system or new insecticides that are environmentally friendly. In these pursuits, we value advancement, fun, balance, respect, fairness, and integrity.
I have been involved in peptide and protein research for over two decades, and am highly experienced in bioinformatics, chemistry, structural characterization, biophysics, and biochemistry. I trained with experts in peptide and protein characterization: an Honours project with Professor Garry King at the University of New South Wales, Sydney, Australia (2004), an APA scholarship with Professor David Craik at the University of Queensland Institute for Molecular Bioscience, Brisbane, Australia (2005-2009) and a NHMRC fellowship with Professor Mingjie Zhang at the Hong Kong University of Science and Technology, Hong Kong, China (2009-2011) and A/Professor Andreas Hofmann at Griffith University Eskitis Institute, Brisbane, Australia (2011-2012). I returned to the University of Queensland in 2012 to join an industry partnership funded by an ARC linkage grant. I currently hold an ARC Future Fellowship and am responsible for a team of research officers, assistants and postgraduate students.
My research output has been recognised by >30 prizes and awards for leadership, research translation and fundamental research excellence, as well as numerous invitations to speak at academic and pharmaceutical conferences. I have over 100 publications and have been cited by researchers from across the world.
Availability
- Dr Conan Wang is:
- Available for supervision
Qualifications
- Bachelor of Engineering, University of New South Wales
- Doctor of Philosophy, The University of Queensland
Research interests
-
Drug Discovery and Protein/Peptide Engineeering
My group uses: 1) computational algorithms to predict drug properties with unprecedented accuracy; 2) molecular libraries capable of screening through billions of drug leads to design drugs efficiently; and 3) nano-sized reaction droplets to capture drug activity to make drugs that actually work.
-
Cancer Therapeutics
My group is interested in developing new cancer therapeutics, particularly those that modulate the immune system or relevant to lung cancer.
Works
Search Professor Conan Wang’s works on UQ eSpace
2014
Journal Article
Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting
Henriques, Sonia Troeira, Huang, Yen-Hua, Chaousis, Steph, Wang, Conan and Craik, David J. (2014). Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting. Chembiochem, 15 (13), 1956-1965. doi: 10.1002/cbic.201402144
2014
Journal Article
Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1
D'Souza, Charlotte, Troeira Henriques, Sonia, Wang, Conan K. and Craik, David J. (2014). Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1. European Journal of Medicinal Chemistry, 88, 10-18. doi: 10.1016/j.ejmech.2014.06.047
2014
Journal Article
Comparison of VILIP-1 and VILIP-3 binding to phospholipid monolayers
Rebaud S., Simon A., Wang C.K., Mason L., Blum L., Hofmann A. and Girard-Egrot A. (2014). Comparison of VILIP-1 and VILIP-3 binding to phospholipid monolayers. PLoS ONE, 9 (4) e93948, e93948.1-e93948.8. doi: 10.1371/journal.pone.0093948
2014
Journal Article
Disulfide-rich macrocyclic peptides as templates in drug design
Northfield, Susan E., Wang, Conan K., Schroeder, Christina I., Durek, Thomas, Kan, Meng-Wei, Swedberg, Joakim E. and Craik, David J. (2014). Disulfide-rich macrocyclic peptides as templates in drug design. European Journal of Medicinal Chemistry, 77 (2), 248-257. doi: 10.1016/j.ejmech.2014.03.011
2014
Journal Article
The cyclic cystine ladder of theta-defensins as a stable, bifunctional scaffold: a proof-of-concept study using the integrin-binding RGD motif
Conibear, Anne C., Bochen, Alexander, Rosengren, K. Johan, Stupar, Petar, Wang, Conan, Kessler, Horst and Craik, David J. (2014). The cyclic cystine ladder of theta-defensins as a stable, bifunctional scaffold: a proof-of-concept study using the integrin-binding RGD motif. ChemBioChem, 15 (3), 451-459. doi: 10.1002/cbic.201300568
2014
Journal Article
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis
Wang, Conan K., Gruber, Christian W., Cemazar, Masa, Siatskas, Christopher, Tagore, Prascilla, Payne, Natalie, Sun, Guizhi, Wang, Shunhe, Bernard, Claude C. and Craik, David J. (2014). Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis. ACS Chemical Biology, 9 (1), 156-163. doi: 10.1021/cb400548s
2013
Conference Publication
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis
Wang, C. K., Gruber, C. W., Cernazar, M., Siatskas, C., Tagore, P., Sun, G., Wang, S., Bernard, C. and Craik, D. J. (2013). Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis. 23rd American Peptide Symposium, Waikoloa, Hawaii, 22-27 June 2013 . Hoboken, NJ, United States : John Wiley & Sons.
2012
Journal Article
Cyclotides insert into lipid bilayers to form membrane pores and destabilize the membrane through hydrophobic and phosphoethanolamine-specific interactions
Wang, Conan K., Wacklin, Hanna P. and Craik, David J. (2012). Cyclotides insert into lipid bilayers to form membrane pores and destabilize the membrane through hydrophobic and phosphoethanolamine-specific interactions. Journal of Biological Chemistry, 287 (52), 43884-43898. doi: 10.1074/jbc.M112.421198
2012
Journal Article
Alpha-1 giardin is an annexin with highly unusual calcium-regulated mechanisms
Weeratunga, Saroja K., Osman, Asiah, Hu, Nien-Jen, Wang, Conan K., Mason, Lyndel, Svard, Staffan, Hope, Greg, Jones, Malcolm K. and Hofmann, Andreas (2012). Alpha-1 giardin is an annexin with highly unusual calcium-regulated mechanisms. Journal of Molecular Biology, 423 (2), 169-181. doi: 10.1016/j.jmb.2012.06.041
2012
Journal Article
Hookworm SCP/TAPS protein structure - A key to understanding host-parasite interactions and developing new interventions
Osman, Asiah, Wang, Conan K., Winter, Anja, Loukas, Alex, Tribolet, Leon, Gasser, Robin B. and Hofmann, Andreas (2012). Hookworm SCP/TAPS protein structure - A key to understanding host-parasite interactions and developing new interventions. Biotechnology Advances, 30 (3), 652-657. doi: 10.1016/j.biotechadv.2011.11.002
2012
Journal Article
Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migration
Xavier, Charles-Peter, Rastetter, Raphael H., Blomacher, Margit, Stumpf, Maria, Himmel, Mirko, Morgan, Reginald O., Fernandez, Maria-Pilar, Wang, Conan, Osman, Asiah, Miyata, Yoshihiko, Gjerset, Ruth A., Eichinger, Ludwig, Hofmann, Andreas, Linder, Stefan, Noegel, Angelika A. and Clemen, Christoph S. (2012). Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migration. Scientific Reports, 2 (1) 241. doi: 10.1038/srep00241
2012
Book Chapter
Cyclotide isolation and characterization
Craik, David J., Henriques, Sonia Troeira, Mylne, Joshua S. and Wang, Conan K. (2012). Cyclotide isolation and characterization. Natural product biosynthesis by microorganisms and plants, part B. (pp. 37-62) edited by David A. Hopwood. Burlington, USA: Elsevier. doi: 10.1016/B978-0-12-394291-3.00024-1
2012
Journal Article
SBAL: A practical tool to generate and edit structure-based amino acid sequence alignments
Wang, Conan K., Broder, Ursula, Weeratunga, Saroja K., Gasser, Robin B., Loukas, Alex and Hofmann, Andreas (2012). SBAL: A practical tool to generate and edit structure-based amino acid sequence alignments. Bioinformatics, 28 (7) bts035, 1026-1027. doi: 10.1093/bioinformatics/bts035
2011
Journal Article
DMAN: a java tool for analysis of multi-well differential scanning fluorimetry experiments
Wang, Conan K., Weeratunga, Saroja K., Pacheco, Chris M. and Hofmann, Andreas (2011). DMAN: a java tool for analysis of multi-well differential scanning fluorimetry experiments. Bioinformatics, 28 (3) btr664, 439-440. doi: 10.1093/bioinformatics/btr664
2011
Journal Article
Promiscuity of carbonic anhydrase II: Unexpected ester hydrolysis of carbohydrate-based sulfamate inhibitors
Lopez, Marie, Vu. Hoan, Wang, Conan K., Wolf, Maarten G., Groenhof, Gerrit, Innocentis, Alessio, Supuran, Claudiu T. and Poulsen, Sally-Ann (2011). Promiscuity of carbonic anhydrase II: Unexpected ester hydrolysis of carbohydrate-based sulfamate inhibitors. Journal of The American Chemical Society, 133 (45), 18452-18462. doi: 10.1021/ja207855c
2011
Journal Article
Divalent cations and Redox conditions regulate the molecular structure and function of visinin-like protein-1
Wang, Conan K., Simon, Anne, Jessen, Christian M., Oliveira, Cristiano L. P., Mack, Lynsey, Braunewell, Karl-Heinz, Ames, James B., Pedersen, Jan Skov and Hofmann, Andreas (2011). Divalent cations and Redox conditions regulate the molecular structure and function of visinin-like protein-1. PLoS One, 6 (11) e26793, e26793.1-e26793.10. doi: 10.1371/journal.pone.0026793
2011
Journal Article
Insights into the membrane interactions of the saposin-like proteins Na-SLP-1 and Ac-SLP-1 from human and dog hookworm
Willis, Charlene, Wang, Conan K., Osman, Asiah, Simon, Anne, Pickering, Darren, Mulvenna, Jason, Riboldi-Tunicliffe, Alan, Jones, Malcolm K., Loukas, Alex and Hofmann, Andreas (2011). Insights into the membrane interactions of the saposin-like proteins Na-SLP-1 and Ac-SLP-1 from human and dog hookworm. PLoS One, 6 (10) e25369, e25369.1-e25369.10. doi: 10.1371/journal.pone.0025369
2011
Journal Article
Atypical (RIO) protein kinases from Haemonchus contortus-promise as new targets for nematocidal drugs
Campbell, Bronwyn E., Boag, Peter R., Hofmann, Andreas, Cantacessi, Cinzia, Wang, Conan K., Taylor, Paul, Hu, Min, Sindhu, Zia-ud-Din, Loukas, Alex, Sternberg, Paul W. and Gasser, Robin B. (2011). Atypical (RIO) protein kinases from Haemonchus contortus-promise as new targets for nematocidal drugs. Biotechnology Advances, 29 (3), 338-350. doi: 10.1016/j.biotechadv.2011.01.006
2011
Journal Article
The role of conserved Glu residue on cyclotide stability and activity: A structural and functional study of kalata B12, a naturally occurring Glu to Asp mutant
Wang, Conan K. L., Clark, Richard J., Harvey, Peta J., Rosengren, K. Johan, Cemazar, Masa and Craik, David J. (2011). The role of conserved Glu residue on cyclotide stability and activity: A structural and functional study of kalata B12, a naturally occurring Glu to Asp mutant. Biochemistry, 50 (19), 4077-4086. doi: 10.1021/bi2004153
2010
Journal Article
Isolation and characterization of Bioactive Cyclotides from Viola labrilorica
Tang, Jun, Wang, Conan K., Pan, Xulin, Yan, He, Zeng, Guangzhi, Xu, Wenyan, He, Wenjun, Daly, Norelle L., Craik, David J. and Tan, Ninghua (2010). Isolation and characterization of Bioactive Cyclotides from Viola labrilorica. Helvetica Chimica Acta, 93 (11), 2287-2295. doi: 10.1002/hlca.201000115
Funding
Current funding
Past funding
Supervision
Availability
- Dr Conan Wang is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Molecular design of drugs for cancer diagnosis, imaging and therapy.
In this industry-linked project, an exceptional opportunity awaits a highly motivated PhD candidate interested in discovery and engineering of peptide drugs to combat cancer.
-
Molecular design of drugs for cancer diagnosis, imaging and therapy.
In this industry-linked project, an exceptional opportunity awaits a highly motivated PhD candidate interested in discovery and engineering of peptide drugs to combat cancer.
-
Design of novel cancer therapeutics to combat drug resistance
Develop a suite of technologies to overcome key challenges in cancer drug resistance.
-
PhD top-up scholarship: Design and manufacturing of next-generation ultra-stable peptide radiotracers for precision diagnosis and therapy
Scholarship + Top-up opportunity for a talented domestic student.
-
PhD top-up scholarship: Technology-driven discovery of sustainable next-generation insecticides
Scholarship + Top-up opportunity for a talented international/domestic student interesting in designing novel ecofriendly insecticides for safeguarding agriculture.
Supervision history
Current supervision
-
Doctor Philosophy
Patient-friendly peptide tracers for improving immunotherapy outcomes
Principal Advisor
Other advisors: Dr Yen-Hua Crystal Huang
-
Doctor Philosophy
Discovery and Development of Substrate-Based Peptide Kinase Inhibitors
Principal Advisor
Other advisors: Dr Yen-Hua Crystal Huang, Professor David Craik
-
Doctor Philosophy
Next-generation IL-2 mimics for immunotherapy
Principal Advisor
Other advisors: Professor David Craik, Professor Di Yu
-
Doctor Philosophy
A new molecular technology platform for design and production of ultra-stable peptides
Principal Advisor
Other advisors: Professor David Craik
-
Doctor Philosophy
Development of a new class of ligase enzymes for protein engineering and drug development
Associate Advisor
Other advisors: Professor David Craik, Dr Thomas Durek
-
Doctor Philosophy
Development of commercially viable cyclic peptide production for the protection of the Great Barrier Reef
Associate Advisor
Other advisors: Professor David Craik, Dr Thomas Durek, Professor Linda Lua
-
Doctor Philosophy
Exploring delivery strategies for cyclotide-based therapeutics
Associate Advisor
Other advisors: Dr Yen-Hua Crystal Huang, Professor David Craik
-
Doctor Philosophy
Development of peptide-based inhibitors for crop protection
Associate Advisor
Other advisors: Professor Brett Collins, Professor David Craik
Completed supervision
-
2021
Doctor Philosophy
The development of peptide-based cholesterol-lowering therapeutics
Principal Advisor
Other advisors: Professor David Craik
-
2024
Doctor Philosophy
Discovery, production, and development of disulfide-rich peptides for drug design and development
Associate Advisor
Other advisors: Professor David Craik, Dr Thomas Durek
-
2023
Doctor Philosophy
Structural Modifications to Optimise the Oxidative Folding and Activity of Cyclotides
Associate Advisor
Other advisors: Dr Simon de Veer, Professor David Craik
-
2023
Doctor Philosophy
Characterising the crown-of-thorns starfish secretome to identify factors for future biocontrol systems
Associate Advisor
Other advisors: Professor Sandie Degnan, Professor Bernard Degnan
-
2022
Doctor Philosophy
Investigating approaches for the design and delivery of disulfide-rich peptide therapeutics
Associate Advisor
Other advisors: Dr Yen-Hua Crystal Huang, Professor David Craik
-
2015
Doctor Philosophy
Structure-activity relationships and development of disulfide-rich cyclic peptides as pharmaceutical templates
Associate Advisor
Other advisors: Professor David Craik
Media
Enquiries
For media enquiries about Dr Conan Wang's areas of expertise, story ideas and help finding experts, contact our Media team: